Most Recent
Global investment banks and executives accused of engaging in criminal cartel conduct in relation to a $2.5 billion ANZ share placement in 2015 will seek to quash the "incomprehensible" indictment filed against them, claiming it is full of "fallacies".
Uber has dragged an Australian IT services company to court after failing to win removal of the company's 'Uber Geeks' trade mark for its home-visiting technician services.
Two NAB units have indicated they will seek to dismiss a lawsuit over alleged MySuper mismanagement which the court recently ruled was not validly commenced as a class action if the lead applicant fails in his bid to replead.
The High Court has dismissed an appeal by Westpac challenging a ruling that found the bank breached its duties to customers by providing personal financial advice as part of a telephone campaign encouraging customers to roll over external superannuation accounts.
Allens has snagged two new heavy hitters from HWL Ebsworth to bolster its corporate team in Perth.
A judge has sided with five investments banks and rejected a bid to amend a class action alleging a series of cartel agreements to rig foreign exchange rates, saying there were "substantial problems" with the proposed pleadings.
The High Court will hand down its ruling Wednesday in a high-stakes case between ASIC and Westpac that is expected to clarify the line between personal and general financial advice.
Lawyerly's Litigation Firms of 2020 delivered significant victories for clients last year in bet-the-company matters, thriving in a tumultuous year that saw courts and litigants adapt to virtual trials and other new norms that are sure to outlast the COVID-19 pandemic.
An account director for Oracle is suing the tech company alleging he was fired for making complaints about one of his superiors who allegedly told him he had "zero EQ" and "an innate ability to annoy and anger people".
Drug giant Merck Sharp & Dohme has brought a cross appeal in its long-running intellectual property dispute with Pfizer's Wyeth over the top selling Prevnar 13 pneumococcal vaccine.